TRENDING TOPICS
3286 articles found for "investing"
Transocean and Valaris announced a $5.8 billion all-stock merger that will create the world's largest offshore drilling contractor with 73 rigs and a $17 billion enterprise value.
Vice President JD Vance and Secretary Marco Rubio will host officials from more than 50 nations this week to expand Project Vault, America's $12 billion critical minerals reserve, into a global purchasing alliance.
CME Group hikes COMEX gold futures margins to 9% and silver to 18%, the highest levels in years, as precious metals endure their most volatile stretch since the pandemic-era turmoil of 2020.
Goldman Sachs projects U.S. IPO proceeds will quadruple to a record $160 billion in 2026, with SpaceX, OpenAI, and Anthropic leading a wave of mega listings that could redefine capital markets.
Cisco Systems reports Q2 FY2026 earnings on Wednesday with analysts expecting $1.02 EPS and $15.1 billion in revenue as AI data center networking demand reshapes the enterprise tech giant.
Kyndryl Holdings stock plunged 54% on Monday after disclosing an accounting review, abrupt CFO and general counsel departures, and an SEC enforcement investigation.
Fed Vice Chair Philip Jefferson delivered a cautiously optimistic speech on the economy, arguing tariff inflation is temporary but signaling rates will stay elevated until the data provides overwhelming evidence of progress.
Palo Alto Networks is pursuing a $25 billion acquisition of Israeli identity security firm CyberArk, a deal that would mark the biggest cybersecurity transaction ever and reshape the industry's competitive landscape.
The US Dollar Index has tumbled more than 10% over the past year to its lowest level since February 2022, as central banks diversify reserves and global investors rethink their dependence on the greenback.
Salesforce shares have plunged 26% year-to-date, making it the second-worst performer in the Dow, as Anthropic's AI automation tools spark fears of a structural disruption to the SaaS business model.
Cleveland-Cliffs reports Q4 2025 revenue of $4.3 billion, missing estimates by $300 million, but projects a $500 million EBITDA improvement in 2026 as steel tariffs rise to 50%.
Eli Lilly acquires Orna Therapeutics for up to $2.4 billion in cash, gaining access to circular RNA technology and an in vivo CAR-T therapy designed to treat autoimmune diseases.